-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Reviva Pharmaceuticals Holdings, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2020 to 2024.
- Reviva Pharmaceuticals Holdings, Inc. Nonoperating Income (Expense) for the quarter ending March 31, 2024 was $496 K, a 265% increase year-over-year.
- Reviva Pharmaceuticals Holdings, Inc. Nonoperating Income (Expense) for the twelve months ending March 31, 2024 was $620 K, a 1655% increase year-over-year.
- Reviva Pharmaceuticals Holdings, Inc. annual Nonoperating Income (Expense) for 2023 was $260 K.
- Reviva Pharmaceuticals Holdings, Inc. annual Nonoperating Income (Expense) for 2022 was -$11.9 K, a 101% decline from 2021.
- Reviva Pharmaceuticals Holdings, Inc. annual Nonoperating Income (Expense) for 2021 was $1.59 M.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)